Navigation Links
Yongye International Announces Second Quarter 2012 Financial Results
Date:8/9/2012

e same period of 2011. Excluding non-cash expenses related to share-based compensation for management and independent directors and the amortization of the acquired Hebei customer list, second quarter 2012 adjusted income from operations was $55.4 million, or 31.2% of sales.* The increase in income from operations was mainly due to the sales growth combined with lower purchase price of certain raw materials.

Net income attributable to Yongye was $41.1 million, or $0.74 per diluted share in the second quarter of 2012, compared to a net income of $39.5 million, or $0.77 per diluted share, in the same period of 2011. The Company recorded non-cash income related to a change in fair value of derivative liabilities of $9,889 in the second quarter of 2012. Excluding the impact of non-cash expenses related to share-based compensation for management and independent directors, the amortization of the acquired Hebei customer list, and a change in the fair value of derivative liabilities, adjusted net income attributable to Yongye for the second quarter of 2012 was $43.0 million, or $0.78 per diluted share, compared to adjusted net income of $40.5 million, or $0.82 per diluted share in the same period of 2011.*

Six Month Financial ResultsRevenue for the six months ended June 30, 2012 increased 18.1% to $242.0 million from $204.9 million for the comparable period in 2011, while gross profit was $143.5 million, compared to $119.1 million in the first six months of 2011. Gross margin was 59.3% for the six months ended June 30, 2012, as compared to 58.1% for the same period of 2011. Income from operations in the first six months of 2012 was $75.4 million, compared to $62.8 million in the first six months of 2011. Net income attributable to Yongye for the first six months of 2012 was $57.5 million, compared to $47.9 million in the prior year period. In the first six months 2012, net income per diluted share was $1.02, as compared to $0.94 diluted earnings per sha
'/>"/>

SOURCE Yongye International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Yongye International to Report Second Quarter 2012 Financial Results on August 9, 2012
2. Dyadic International to Announce Second Quarter 2012 Financial Results and Host Conference Call on Monday, August 13, 2012
3. SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
4. Elsevier Launches International Journal for Parasitology: Parasites and Wildlife
5. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
6. Bunker Hill Community College Student Speaks at 2012 BIO International Convention
7. International Probiotics Association Excited To Learn The FDA Has Decided To Issue A New, Revised NDI Draft Guidance
8. Promoting the States Quality of Life, New Jersey Symphony Orchestra to Perform at BIO International Convention
9. International Survey of T2* Cardiovascular Magnetic Resonance in Thalassemia
10. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
11. QIAGEN Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The Oklahoma tornado left the state ... mayor of Moore, one of the heavily damaged towns, proposed ... from cnn.com. Reaching out to also be of help, My ... Shield to counter the looming mold problem. , The ... 2013, caused 24 deaths, My Cleaning Products shared. Ten of ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Quincy ... discovery and development of calcium-binding proteins to support ... safety assessment study of apoaequorin in ... journal published for the British Industrial Biological Research ... was to investigate potential adverse effects, if any, ...
(Date:5/23/2013)... Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just praying that ... few doctors said he had a good chance of ... her now 20-month-old son, Kaiba. "At that point, we ... it and run with it." , They found hope ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
Breaking Biology Technology:Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3
... 2011 NeoStem, Inc. (NYSE Amex: NBS ) ... focus on cell-based therapeutic development, today announced that the Company ... Wednesday evening, August 24, 2011. The segment focused ... adult stem cells for first responders, the nuclear industry, the ...
... Calif., Aug. 25, 2011 Emmy® and Tony® award-winning ... ) today launch Act 2 Reduce Fractures™, an educational ... for fractures. Earlier this year, Danner was diagnosed with ... to encourage women like her to educate themselves, take ...
... New Leaf Venture Partners (NLV Partners) have contested the terms of ... (NYSE: PFE ) in a letter filed today with ... plans to purchase the shares of Icagen stock it already does ... an aggregate transaction value of approximately $56 million.  In the past ...
Cached Biology Technology:Stem Cell Treatments for First Responders in the News 2Stem Cell Treatments for First Responders in the News 3Stem Cell Treatments for First Responders in the News 4Stem Cell Treatments for First Responders in the News 5Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 2Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 3Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 4Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 5Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 6Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures™ Educational Campaign 7Merlin Nexus and New Leaf Venture Partners Continue to Contest Proposed $56 Million Acquisition of Icagen by Pfizer 2Merlin Nexus and New Leaf Venture Partners Continue to Contest Proposed $56 Million Acquisition of Icagen by Pfizer 3
(Date:5/23/2013)... have succeeded in treating cerebral palsy with autologous cord ... a 2.5 year old boy had been in a ... Just two months after treatment with the cord blood ... following months, the child learned to speak simple sentences ... a Korean study, dispel the long-held doubts about the ...
(Date:5/23/2013)... MADISON, Wis. In an age when microbial pathogens ... to tamp down infection, a team of Wisconsin scientists ... of curbing the bacteria that cause staph infections. , ... Chemical Society , a group led by University of ... interfere with the "quorum sensing" behavior of Staphylococcus ...
(Date:5/22/2013)... technique that can detect molecular variants in chemical mixtures ... the most important, though time-consuming, processes in analytical chemistry. ... Nature , post-doctoral researcher David Patterson, Professor of Physics ... for Free-Electron Laser Science (CFEL) in Hamburg, Germany developed ... identify molecular variants apart, and to determine how much ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2University of Wisconsin chemists find new compounds to curb staph infection 2Detecting mirror molecules 2Detecting mirror molecules 3
... at a number, letter or other shape, neurons in ... different components of that shape, almost instantaneously fitting them ... the individual then "sees" and understands, researchers at The ... university's Zanvyl Krieger Mind/Brain Institute describes the complex but ...
... tracking of new drugs for commercial licensing are raised by ... approval of natalizumab, a new drug for multiple sclerosis, and ... a life threatening condition while being treated. , Natalizumab was ... for use in relapsing multiple sclerosis on the basis of ...
... of a fundamentally new "candidate," or potential, vaccine for ... people annually, is reported in the current issue of ... of infected female sand flies, visceral leishmaniasis infects about ... in India, Bangladesh, Nepal, Sudan and Brazil. , Despite ...
Cached Biology News:In the mind's eye: How the brain makes a whole out of parts 2Potential vaccine developed for deadly leishmaniasis disease 2Potential vaccine developed for deadly leishmaniasis disease 3
... to meet your laboratory's requirements for data management and quality control. ... ... ... is the standard software for Staccato Systems and custom Allegro Modules allowing for the simple interface ...
... This microscope is described by end-users to ... incorporates the fundamentals of light microscopy and ... small footprint, it does not require much ... a busy lab environment. The DM-BA300 combines ...
The LAS-3000 imaging system combines new CCD camera technology with a simplified user interface to provide significantly improved system sensitivity with a wide range of modularities. This system is...
... Life Science LAS-3000mini is a compact ... chemiluminescence applications, and the perfect standard ... 's LAS-3000 provides significantly improved system ... Glowell calibration standards validate that Fujis ...
Biology Products: